Views
1 year ago

Dengue Vaccines Market

Dengue Vaccines Market Outlook – Research Pipeline There are approximately five vaccine candidates under evaluation in clinical trials, including other live-attenuated vaccines, as well as subunit, DNA and purified inactivated vaccine candidates. Also, technological approaches, such as virus-vectored and VLP-based vaccines, are under evaluation in preclinical studies. In September 2016, Takeda announced the beginning of the phase 3 clinical trials of its dengue vaccine – TAK-003 vaccine. This vaccine is also aimed at prevention against all four dengue virus strains.

Report Description

Report Description Dengue Vaccines Market Outlook – Research Pipeline There are approximately five vaccine candidates under evaluation in clinical trials, including other liveattenuated vaccines, as well as subunit, DNA and purified inactivated vaccine candidates. Also, technological approaches, such as virus-vectored and VLP-based vaccines, are under evaluation in preclinical studies. In September 2016, Takeda announced the beginning of the phase 3 clinical trials of its dengue vaccine – TAK-003 vaccine. This vaccine is also aimed at prevention against all four dengue virus strains. Dengue is a mosquito-borne flavivirus debilitating disease with high prevalence in most tropical and subtropical regions. Dengue is a painful disease that is also known as ‘break bone’ fever due to the excruciating bone and joint pain associated with it. No therapeutics have been discovered for treatment of the disease caused by four closely related dengue viruses (DEN-1, DEN-2, DEN-3 and DEN-4). Therefore, focus has been mainly on prevention by controlling the vectors being borne. Severe dengue was discovered in the 1950s during dengue epidemics in Philippines and Thailand. The disease has since spread to Asian and Latin America countries and is one of the leading causes of hospitalization and deaths among children and adults in these regions. Get free Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/23 Prevalent Scenario in the Global Dengue Vaccines Market Member states in three of the WHO regions regularly report the annual number of dengue cases. These statistic suggest that the number of dengue cases increased from 2.2 million in 2010 to 3.2 million in 2015. The actual number remains underreported. One recent estimate by Bhatt et al., (also quoted by the WHO) mentions that there are around 390 million dengue cases worldwide each year, with number of cases reported increasing each year. In 2015, 2.35 million cases of dengue were reported in the Americas alone, of which 10,200 cases were diagnosed as severe dengue that led to 1,181 deaths. Dengue is a pertinent health issue affecting people across South America, Europe, and Asia. A large number of dengue outbreaks were reported worldwide in 2015, with over 169,000 cases in the Philippines and over 111,000 suspected cases of dengue in Malaysia. This was a staggering 59.5% and 16% increase respectively in the number of cases compared to that in 2014. The global dengue vaccines market therefore, offers lucrative growht opportunities for vaccine manufacturers. Dengvaxia – the only approved product in the global dengue vaccines market Sanofi Pasteur’s Dengvaxia, is the culmination of over two decades of scientific innovation and collaboration. The vaccine received its first marketing authorization in 2015, in Mexico. Dengvaxia is the world’s first licensed vaccine for prevention of dengue. It is a tetravalent dengue vaccine that prevents the disease from all four dengue viruses in people aged 9 to 45 years. Sanofi launched the world’s first public dengue vaccination program in the Philippines (2016), followed by Brazil. Dengvaxia is approved in 10 endemic countries worldwide, namely, Singapore, Mexico, the Philippines, Paraguay, Brazil, El Salvador, Costa Rica, Indonesia, Peru, and Guatemala. The global dengue vaccines market is thus, expected to expand with growing market approvals. Ask for Request Customization @ https://www.coherentmarketinsights.com/insight/requestcustomization/23

India is however taking a precautionary approach in approving this vaccine due to lack of studies among the population in the country. A scientist in India has developed a dengue vaccine that was successfully tested in monkeys. If successful in human trials, this could be a breakthrough invention for prevention of dengue among the populace in the country. Moreover, various philanthropists and global organizations are investing in developing vaccines for malaria and dengue. About Us COMPANY OVERVIEW Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. Our team is of the most vital cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive defusion training module.This allows for an objective and unbiased assessment of the market. We pride ourselves in my constantly striving to update our extremely in-depth understanding of the market by closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth path in the future. Contact Us CORPORATE OFFICE: Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel No: (+1)206-701-6702 Email: sales@coherentmarketinsights.com Website: https://www.coherentmarketinsights.com/

Dengue Vaccines Market Value Share, Supply Demand, share and Value Chain 2016-2026
Jacqueline Lim - Dengue Vaccine Initiative
DEVELOPMENT OF DENGUE VACCINES
Animal Vaccines Market Size to Expand Significantly by the End of 2023
Steatohepatitis Global Clinical Trials Review, H1, 2015: Market Growth, Commercial Landscape, Analysis: ResearchBeam
Global Thymus Carcinoma Clinical Market Trials Review 2015 - Market Trends, Size, Share, Growth, Regulations, and Competitive Landscape
Pediatric Vaccines Market
Intestinal Cancer Global Clinical Trials Review 2015 Market Trends, Size, Demand, Cost, Opportunity Analysis
Global Companion Animal Vaccines Market
Refrigerated Display Cases Market Value Share, Analysis and Segments 2015-2025 by Future Market Insights
Clinical Trials Market
Global Veterinary Vaccines market Research Report
Global Veterinary Vaccines market Research Report
Personalized Medicine Market Value Share, Supply Demand, share and Value Chain 2016-2026
Meningococcal Vaccines Market
Veterinary Vaccines Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025: Future Market Insights
Optic Neuropathy Global Clinical Trials Review, H1, 2015: Market Growth, Commercial Landscape, Analysis
2014 Aspergillosis Global Clinical Trials Review, H2: Market Growth, Commercial Landscape
Synovial Sarcoma Global Clinical Trials Review 2015 Market Trends, Size, Demand, Cost, Opportunity Analysis
Myxoid Liposarcoma Global Clinical Trials Review 2015 Market Trends, Size, Demand, Cost, Opportunity Analysis
[+]The best book of the month Laboratory Animals in Vaccine Production and Control: Replacement, Reduction and Refinement (Developments in Hematology and Immunology) [READ]
Anaplastic Thyroid Cancer Global Clinical Trials Review 2015 Market Trends, Size, Demand, Cost, Opportunity Analysis
Pilocytic Astrocytoma Global Clinical Trials Review 2015 Market Trends, Size, Demand, Cost, Opportunity Analysis
Follicular Thyroid Cancer Global Clinical Trials Review 2015 Market Trends, Size, Demand, Cost, Opportunity
Analysis on Optic Neuropathy Market Global Clinical Trials Review, H1, 2015
Aneurysm Global Clinical Trials Review 2015 Market Trends, Size, Demand, Cost, Opportunity Analysis
Subependymal Giant Cell Astrocytoma Global Clinical Trials Review 2015 Market Trends, Size, Demand, Cost, Opportunity Analysis
Round Cell Liposarcoma Global Clinical Trials Review 2015 Market Trends, Size, Demand, Cost, Opportunity Analysis
Islet Cell Carcinoma (Insulinoma) Global Clinical Trials Review 2015 Market Trends, Size, Demand, Cost, Opportunity Analysis
Medical Packaging Market Research Report - Global Forecast Till 2023